Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available

Mariana P Socal; Ge Bai; Gerard F Anderson

doi:10.1001/jamainternmed.2018.7824

Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available

JAMA Intern Med. 2019 Jun 1;179(6):832-833. doi: 10.1001/jamainternmed.2018.7824.

Authors

Mariana P Socal¹, Ge Bai², Gerard F Anderson¹

Affiliations

¹ Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
² The Johns Hopkins Carey Business School, Baltimore, Maryland.

Abstract

This study examines Medicare Part D prescription drug plans to assess how often branded products were given more favorable formulary placement than generic products.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Costs / statistics & numerical data
Drug Prescriptions / economics*
Drugs, Generic / economics*
Humans
Insurance, Pharmaceutical Services / economics
Medicare Part D / economics*
Prescription Drugs / economics*
United States

Substances

Drugs, Generic
Prescription Drugs